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Abstract: 
Proteomics is one of the pivotal next generation biotechnologies in the current “postgenomics” 
era. Little is known about the ways in which innovative proteomics science is navigating the 
complex socio-political space between laboratory and society. It cannot be assumed that the 
trajectory between proteomics lab and society is linear and unidirectional. Concerned about 
public accountability and hopes for knowledge-based innovations, funding agencies and citizens 
increasingly expect that emerging science and technologies, such as proteomics, are effectively 
translated and disseminated as innovation-in-society. Here, we describe translation strategies 
promoted in the knowledge translation (KT) and science communication literatures and 
examine the use of these strategies within the field of proteomics. Drawing on data generated 
from qualitative interviews with proteomics scientists and ethnographic observation of 
international proteomics conferences over a 5-year period, we found that proteomics science 
incorporates a variety of KT strategies to reach knowledge users outside the field. To attain the 
full benefit of KT, however, proteomics scientists must challenge their own normative 
assumptions and approaches to innovation dissemination – beyond the current paradigm 
relying primarily on publication for one’s scientific peers within one’s field - and embrace the 
value of broader (interdisciplinary) KT strategies in promoting the uptake of their research. 
Notably, the Human Proteome Organization (HUPO) is paying increasing attention to a broader 
range of KT strategies, including targeted dissemination, integrated KT, and public outreach.  
We suggest that increasing the variety of KT strategies employed by proteomics scientists is 
timely and would serve well the omics system sciences community. 
3 
 
 
 
 
 “Research is not used as a can opener is used” 
Huberman, 1987, as quoted in Graham et al., 2006. 
 
Introduction 
Research cumulatively builds knowledge. In the omics sciences a prerequisite to knowledge 
building is acknowledging the interconnected nature of its fields. The evolution of complex 
biomedical knowledge has seen increasing diversity together with disciplinary specialization, 
and a growing need for these disciplines to work together, along with non-scientists 
knowledgeable about policy and applications, in order to solve the persistent challenges 
humans face. At the same time, specialization drives communicative and perceptive wedges 
between these different fields, disciplines and sectors, making collaboration a challenge.  Given 
the persistence of these collaborative challenges and the importance of the objectives that 
these different disciplines are hoping (and in some cases, committed) to achieve, it is little 
surprise that an area of specialization has emerged to order the chaos. In this context, 
knowledge translation (KT) is the practice of turning the multidisciplinary evidence generated 
by scientific discovery into actions and outcomes – through, for example, the generation of 
recommendations for clinical applications, realignment of funding agenda and priorities, service 
and program planning, and policy or regulatory reforms.   
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KT, as a specific field of research into the process of how knowledge is translated, was originally 
applied primarily to the clinical practices research (Curran et al., 2011; Graham et al., 2006; 
Grimshaw et al., 2012).  It is now applied to research more generally (for example, National 
Centre for the Dissemination of Disability Research, 2005, Technical Brief Number 10).  
Scientists have been concerned about distributing knowledge appropriately and effectively to 
knowledge users and this has long been an area of study for social and health researchers from 
a variety of perspectives.  For example, broad and long-standing interest in the spread of 
knowledge and innovation is contained in the works of Popper (1962), Basalla (1967), Foucault 
(1980), Habermas (1984), Mayo and Hollander (1991), Gambardella (1995), and Nonaka and 
Takeuchi (1995) among many others.   
 
The wide range of interest in the movement of knowledge from researchers to knowledge users 
is represented in works on knowledge dissemination, knowledge implementation, knowledge 
transfer, knowledge mobilization, and knowledge brokering, for example, depending on the 
specific focus of interest and disciplinary background of the authors (Shaxson et al., 2012; 
Graham et al., 2006).  
 
The concept of KT was first used as a criterion for funding by the Canadian Institute of Health 
Research (Canadian Institute of Health Research, 2014; Graham et al., 2006).  It is now used by 
many other funding agencies, although an international study indicates that there is 
considerable variation in the form of KT funding agencies expect (Tetroe et al., 2008). Part of 
the appeal of KT is its addressing of the widespread knowledge to action gap (Bowen and 
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Graham, 2013), particularly in the midst of public debates about the value of research (Wilsdon 
et al. 2005).  Grimshaw et al. (2012) discuss the persistent failure of research to translate easily 
into practice and policy, citing studies that suggest as little as 11% compliance with research-
generated health care recommendations.  Funders are therefore increasingly focused on 
requiring researchers to provide a plan for dissemination and translation of their results due to 
the social and political expectation for a return on public investment in research (Besley, 2015; 
Ozdemir et al. 2015; Tetroe et al., 2008; Wilson et al., 2010). KT is therefore the conduit for 
both the science push to supply new information and technologies and the user demand (pull) 
for them; it is used to explain the relevance of findings to those who fund research, and those 
who are designing the programs and policies that use that new information, and it helps 
researchers define priorities through identifying where the need for new evidence or diagnostic 
or treatment tools is most urgent or relevant. 
 
The concept of KT performs two essential functions of relevance to omics system sciences and 
technologies.  The first is that KT tackles the thorny problem of how to strategically cross 
disciplinary boundaries (Dobbins et al., 2007). For omics sciences that depend on multiple 
disciplinary specialization, it is particularly important to connect the Big Data and 
computational systems of different specialties to an integrated and overarching understanding 
of the mechanisms underlying biological processes.  Secondly, KT, if done well, may encourage 
a better general understanding of science and scientific processes – which can be a significant 
boon to marshalling resources such as political will.  
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Traditional paths of dissemination of research in scientific journals do not achieve these wider 
translational goals (Grimshaw et al., 2012) and funding agencies are increasingly aware of this 
(Tetroe et al., 2008).  For example, in 2008, 45% of 33 international funding agencies surveyed 
required a report on communications activities and 24% required a report for decision makers 
(Tetroe et al., 2008). Still, traditional scientific dissemination routes – publishing or presenting 
results at conferences or publishing in peer reviewed journals within one’s own field – are a 
necessary part of an effective research practice and scientists’ personal career development 
agenda. Considered to be the primary products conferring status and prestige in scientists’ 
careers, these methods of dissemination have been and continue to be important (Hagstrom, 
1965; Hess, 2007; Merton, 1973).  Publication is often the form of dissemination upon which 
the most emphasis is placed, not only for the scientist’s time, but also for grant funding, 
promotion, and other career rewards.  
 
In this paper we integrate KT theory illuminated by insights from three fields, namely, science 
and technology studies (STS), public understanding of science (PUS), and science 
communication, in order to map the different forms of dissemination available to (and 
sometimes utilized by) proteomics scientists.  From interviews with, and observations of 
proteomics scientists during five years of proteomics conferences, we identified and analyzed 
the KT strategies that are currently employed in the proteomics field.   
 
While our analysis shows that significant attention is still focused on traditional disciplinary 
knowledge exchange, proteomics scientists and a scientific consortium, the Human Proteome 
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Organization (HUPO) are paying more attention to a broader range of KT strategies, including 
targeted KT, integrated KT, and public outreach (see Table 1).  Although this is encouraging, we 
suggest that increasing the variety of knowledge translation strategies employed by scientists 
would benefit the omics sciences. 
 
Our data suggest that proteomics scientists recognize the necessity of engaging in KT, either 
because funding agencies are increasingly requiring it or, given the limited pool of resources, 
there is a need to justify to the public, funders, or even other scientists why proteomics should 
be funded.  We detail this perspective, along with the dissemination strategies that proteomics 
scientists are using.  
 
Methods 
Data on how proteomics scientists are engaging in KT were collected using ethnographic 
research methods, including fieldnotes from participant observation of conferences over a 5-
year period (2011-2015) and qualitative interviews with researchers. Additional information on 
the methods can be found in Holmes et al. (2016). Participant observation (Emerson et al. 2011; 
Hammersley and Atkinson, 2007) to further our understanding of actual KT and dissemination 
strategies within proteomics science, was carried out at the HUPO conferences (2011-2015) and 
the Australasian Proteomics Society (APS) (2012-2013). Field notes were taken during all 
conferences, with attention to scientific discussions and the content of presentations, including 
questions and responses. Open ended, qualitative interviews (Kvale, 1996) (N=36) focused on 
the role of standards and KT. Interviews were conducted primarily with proteomics scientists, 
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either face to face in their laboratories/offices or via telephone and Skype. Scientists were 
recruited through web searches of universities in Canada and Australia, at national and 
international conferences, or by the snowball method (i.e., recommendations from scientists 
interviewed). The data (interview transcripts, field notes, and documentary sources) were 
analyzed thematically by Holmes using qualitative analysis software (Atlas Ti). 
 
Research Independence 
This research project was independently funded as part of wider study on standardization and 
knowledge translation by the Canadian Institute of Health Research. While some social science 
research on the ethical, legal, and social aspects (ELSI) of new technologies is ‘embedded’ 
within larger scientific projects as a requirement of research funding (Lopez and Lunau, 2012), 
this project was not directly tied to any proteomics scientific research or organization. 
 
Research Ethics Approval 
The project received ethical approval from both Dalhousie University’s and Queensland 
University of Technology’s Human Research Ethics Committees.   
 
Knowledge Translation Strategies 
Examining the KT literature and the literature on PUS and science communication, as well as 
our observations of KT within the proteomics community, we identified four KT strategies.  We 
consolidated the terminology across these strategies, as the literatures on KT, dissemination, 
and science communication use a variety of terms to describe these categories (Table 1).   
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[Insert ‘Table 1. An overview of four knowledge translation (KT) strategies’ here] 
 
 
A key insight for undertaking dissemination as a KT process is the importance of identifying and 
engaging the knowledge user.  This involves recognition that, “At each phase of knowledge 
creation, knowledge producers can tailor their activities to the needs of potential users.” 
(Graham et al., 2006).  In the next sections of this paper, we critically examine how the 
proteomics scientists we interviewed and those observed at HUPO are engaging with the KT 
strategies outlined in Table 1, and the different knowledge users these strategies incorporate. 
 
Results 
 
Traditional KT 
As described in the introduction, traditional KT, i.e., attending conferences and publishing in 
specialized scientific journals, is the core business for proteomics, and in fact, all academic 
scientists.  For the most part, this category of KT was not directly addressed by those we have 
interviewed, but rather it fits into the ethnographic category of “that which goes without 
saying”, something so culturally important that it does not need to be directly discussed since 
its existence and relevance are assumed.  Awareness of the traditional KT model manifested in 
interviews and presentations when scientists discussed their publications, with the assumption 
that publication in one’s field is what is most important.  When discussing situations where 
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making a choice about research direction might limit future publications, the proteomics 
scientists we interviewed acknowledged that publication within their own field to their peers 
was critically important for grants and career promotion.  For example, one scientist suggested 
that more research is done on biomarker discovery, as opposed to biomarker validation, 
because the latter produces fewer career rewards (promotion, funding):   
They want to have a paper out. … [Validation is] hard work and it is not appreciated by 
the scientific community. Discover biomarkers and you don’t need many samples, but 
then there are a lot of papers. This is what you need for the career. To validate this, 
now we need to have thousands, maybe 10 thousand samples. And then what can 
happen? You validate this - great. You have another paper, after 2-3 years, one paper. 
(Proteomics Scientist (PS1))   
 
Publication within one’s field is an important basic category of dissemination for career 
advancement.  This is an obvious yet important point, given that work in the other categories of 
knowledge dissemination, listed below, is often pursued only in combination with this 
traditional KT. Despite the continuing importance of traditional KT for career development, 
some proteomics scientists interviewed emphasized the increasing importance of broadening 
their approach to KT in order to engage with other knowledge users and other audiences.  
Some recognized that there was value in learning to talk about their field to different audiences 
using less technical language: 
We are so narrow minded, because we are mainly talking to each other and using our 
technical language and now we have to switch and explain what you are doing, for 
instance, to your mum.  I think this [KT] is really needed. (PS1) 
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Awareness of the value and importance of connecting with different audiences is combined 
with an increasing call by funding bodies for expanded KT strategies. 
The grant thing, we have to have a KT section now, and most people think that that is 
a load of [nonsense]. A lot of us feel we just need to write down all the favorite words 
of KT. But actually when we started doing it I took it seriously as I now am consciously 
aware of the great value of KT. (PS2) 
 
This quote indicates that not all proteomics scientists share an equal appreciation of the value 
in broadening their KT strategies.  
 
In the following sections we critically examine the engagement by proteomics scientists with 
non-traditional KT strategies.  As a qualitative study, it is noteworthy that we do not present 
here quantitative data that might suggest how widespread these KT practices are within 
proteomics.  
  
Targeted Knowledge Translation 
Targeted KT recognizes that others outside of your area of specialty may use the knowledge 
you create, that those knowledge users should be identified, and that knowledge should be 
communicated in a manner tailored for that audience (Dobbins et al., 2007; Dobbins et al., 
2009a).  In the context of proteomics, our data suggest that proteomics scientists identify at 
least three knowledge user targets for KT: scientists in related areas (for example other omics 
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sciences and biology), to advance systems biology knowledge; trainees, to build capacity; and 
other proteomics teams, to foster collaboration.  
 
Scientists in other fields 
Proteomics scientists may specifically target scientists in other omics fields, biologists, or (for 
those interested in clinical applications), clinicians as potential knowledge users. It was 
suggested that translating proteomics knowledge to related disciplines was important for two 
reasons.  One is the role of proteomics within the wider omics sciences: proteomics needs to be 
integrated with other omics fields (metabolomics, transcriptomics, genomics, etc.) in order to 
advance understanding of a systems approach.   
I think unless you put all bits of the story together in a systems approach, you are going to 
miss the spectacular color of the human being (PS3) 
 
Therefore integrating proteomics with other omics sciences through the use of targeted KT is 
important and necessary to the development of knowledge. 
 
The second reason that was advanced for proteomics to reach out to other related fields was 
the suggestion that proteomics was more a set of techniques for solving problems than a field 
of knowledge; it therefore requires interaction with other fields in order to be relevant. 
Proteomics by nature is an applied science, so it needs to be applied. And proteomics 
should be used as genomics to solve a biological or biomedical problem. We are not 
biologists, we are not medical doctors, and so we are collaborating with these people. … 
Whoever wants to work with us and has good questions to be answered and has the 
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samples which are required for answering these questions [are or should be the focus of 
targeted KT strategies]. (PS1) 
 
Targeted KT is carried out in two ways within proteomics.  First, targeted KT is undertaken using 
a variant of traditional KT recognizing a broader group of stakeholders.  The key dissemination 
methods for traditional KT, attending conferences and publishing in journals, are used but 
proteomics scientists attending conferences in other fields and target journals likely to be read 
by the wider scientific community. For example, one speaker in a keynote at HUPO 2014 argued 
that proteomics scientists need to publish proteogenomic papers not in proteomics journals, 
but in genomics journals so that the proteomics community can show the genomics community 
the extra analysis proteomics can offer.  The degree to which extensive work is required for this 
kind of activity is somewhat contested within proteomics. Another scientist, for example, 
commented that: “I think proteomics as a tool for trying to understand basic biology is 
reasonably well understood by those people who are relevant” (PS4).  He went on to suggest 
that interdisciplinary KT with biology, for example, was more established than translation to 
clinical and policy arenas. 
 
At an organizational level, HUPO facilitates this kind of targeted KT by inviting scientists from 
other omics sciences, for example, genomics and metabolomics, as well as early career clinical 
researchers, to its conferences to help bridge the boundaries between the fields.    
 
Trainees 
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A broader conceptualization of targeted KT suggests it includes additional strategies to build 
capacity, such as influencing student education.  This includes attempts to recruit 
undergraduate science and bioinformatics students into proteomics science.  A number of 
proteomics researchers we interviewed note that this form of KT is essential for the future 
development of the field.  These individuals mentioned working to change the undergraduate 
curriculum to include omics technology and access to a mass-spectrometer, as a way of 
educating and informing students about proteomics.  Others focused more on the need for 
proteomics students to receive education that would allow them to better bridge disciplinary 
gaps. 
I mean I think no one would deny that having cross-disciplinary knowledge is an advantage. 
[...] So I would have to say the knowledge translation comes from having a broad based 
education initially and I think that is really important to get to know the language of clinical 
medicine and pathology […] I would really encourage actually recommending that basic 
science PhDs do biomedical topics like physiology, anatomy, and those sorts of courses. 
(PS2) 
 
These initiatives are targeted KT, in the sense that they are identifying students as knowledge 
users and transmitting particular types of information to them.  But these strategies are also 
building capacity and laying the groundwork for better KT in general. 
 
Other proteomics teams 
At a broader organizational level, HUPO and its members have examined the dissemination and 
KT strategies employed in related fields, such as genomics, and have adopted similar models.  
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This may assist communication of research to other connected scientific fields. The Human 
Proteome Project (HPP) is a HUPO initiative and models itself on the Human Genome Project 
(HGP).  The HPP organizes the generation of new knowledge by encouraging collaboration 
between proteomics laboratories to map proteins onto chromosomes or disease states. The 
funding for such efforts varies depending on the country in which the group working on a 
particular chromosome is located. For example, the HPP study of Chromosome 6 is hosted in 
Canada (Borchers et al., 2014) and as of 2011 involved as clinical, academic, and industrial 
partners: nine Canadian universities, the Networks of Centres of Excellence Canada, some 
international collaborators, Genome Quebec, Genome BC, Genome Canada, various health 
research institutes, Novartis, Astellas, Roche, AstraZeneca, Janssen, Affymetric, and IDT, among 
others (Keown, 2011).  As well as organizing the generation of new knowledge, the HPP acts as 
a KT tool, organizing that information, once collected, for effective dissemination.  At HUPO 
2013, one speaker noted that the HPP is important for the field of proteomics, not only to 
identify more proteins, but also to reach out to biologists and the broader life sciences to gain 
recognition for proteomics science and to disseminate techniques and results.  It was therefore 
critical, he added, to promote the HPP nationally and regionally and to secure long term 
funding. This, he argued, would integrate omics information and add to translational omics. The 
mapping process makes research results usable by those in, for example, genomics science as it 
maps onto chromosomes, or for clinicians as it maps on to disease states. This example 
suggests that effective KT across disciplines may require new structures, templates, and tools 
that change practice for knowledge producers, but which create and communicate knowledge 
in a way that will be more understandable for knowledge users. While these collaborations with 
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knowledge users may emerge organically rather than intentionally, they tread the border 
between targeted KT and integrated KT, to which we now turn. 
 
Integrated KT 
An integrated KT strategy (sometimes also referred to as engaged scholarship) involves the 
needs of knowledge users shaping research (Bowen and Graham, 2013).  The knowledge user is 
intricately involved in the entire research project, ensuring the relevance and accessibility of a 
project’s information (Pleblani and Marincola, 2006). One of the common ways in which our 
interviewees and the conference participants talked about integrated KT was through the 
concept of working in multidisciplinary teams.  For instance, one researcher suggested that this 
was helpful for better understanding the data that proteomics can generate. 
So that’s why when we do any proteomics or any genomics approaches more towards the 
disease angle, we always bring clinicians into our study because once we have these 
interactome maps or networks being generated, the next fundamental question is what did 
I learn from this network that works towards diseases? So that’s where the clinicians come 
into play. Very handy because they can understand what the relevance of these proteins is 
in the context of diseases. (PS5) 
 
In addition to providing increased understanding for proteomics scientists and improved 
usability and relevance of data, integrating persons with different areas of expertise into 
proteomics projects may be important in communicating the current limitations of proteomics 
techniques.  Unrealistic expectations are something that several researchers mentioned as a 
barrier to working with those in other fields. 
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I think the biggest challenge is appropriately focusing for other fields the real limitations of 
current research. So we could easily flip through a journal and show a group that did a 
great job, very good experiments, [using a]… flash frozen tissue sample from a freezer… 
although that can be achieved, here is the depth of analysis for that given sample, and here 
is how that depth of analysis fits-typical biology questions.  That is often the jump that is 
not quite made so that an excited clinician says, “That’s fantastic. I have a lot of samples in 
my freezer from a very well described patient set that is probably extremely relevant and 
interesting.”-But it may still be a jump to achieve the type of analysis and detection in 
quantitation of proteins or modifications that they think pertain to their disease. It is tough 
news. It is tempering expectations like that. (PS6) 
 
This indicates the practical difficulties of integrated KT projects, such as the time needed to 
communicate the best uses of proteomics technology and the requirements for sample 
preparation.  
 
We also observed that sometimes multi-disciplinary teams were more apparent than real, in 
that the teams sometimes operated in a silo-ized fashion when, for instance, each group (e.g., 
genomics, proteomics, etc.) within a funded multidisciplinary team would pursue their own 
lines of research.  While genuinely integrated KT teams may be rare, that does not mean that 
collaborative projects that, to some extent, separate specialty areas are not useful to 
knowledge users.  There are some hybrid examples, such as those discussed at the HUPO 2015 
conference funded by the National Cancer Institute (NCI), where genomics and proteomics 
research into cancer tumors operate separately at the initial stage.  Results between the two 
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areas are then compared, allowing targeted investigation into the biological reasons for the 
similarities and differences in results and hopefully leading to new, clinically relevant, scientific 
knowledge. 
 
Ideally, integrated KT requires that the research questions are designed to meet the needs of 
the knowledge users.  This involves substantial communication with knowledge users at the 
design stage of a project.  Özdemir et al. (2015) suggest that incorporating this kind of ‘pull’ of 
society’s needs into the lab is as important to innovation in proteomics as is the ‘push’ from the 
laboratory to society.  Examples of this kind of integrated KT were considerably rarer than 
multidisciplinary projects, perhaps because much proteomics research is still at the exploratory 
stage.  One researcher we interviewed noted the importance of integrated research, stating: 
“One day when the field will have the clinicians at the forefront, in my view, that’s when the 
real clinical discoveries are going to be made.” (PS7)  Another researcher commented that 
research collaborations, while a struggle, are important for connecting different kinds of omics 
knowledge. 
The question of how you do team science is critical. So this is exactly responding to your 
question because we need different kinds of expertise to do comprehensive omics 
research, genomics, proteomics, epigenomics, transcriptomics, metabolomics, 
microRNA-omics… whatever!  The aim, of course, is to connect it all the way to the 
phenotypes. So that involves other people, clinical people or biological people looking at 
phenotypes. So, we learn to do this from an educational point of view and we strive to 
do this in our research collaborations Sometimes it works better than others. Some 
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people, some individuals, actually have proficient expertise in multiple areas or at least 
two areas and can be very effective bridge people or leaders of such groups (PS3) 
 
This highlights the importance of those individuals who have some degree of multi-disciplinary 
expertise acting as knowledge translators between areas. 
 
A good example of incorporating a knowledge user’s question into research design would be 
Jean-Charles Sanchez’s account of his research into stroke biomarkers at the HUPO 2013 and 
2015 conferences. While proteomic research has been undertaken to identify stroke 
biomarkers, many of these biomarkers establish whether a patient has had an ischemic or 
hemorrhagic stroke, which can already be easily determined by existing technology (e.g., CT 
scan).  After discussions with physicians, Sanchez realized that what would add value was a 
biomarker that identified the length of time that had elapsed since an ischemic stroke had 
occurred.  The optimal treatment window for patients who have had an ischemic stroke is 
within three hours of the stroke occurring; after five hours the treatment is potentially fatal to 
the patient.  This information is critical as physicians are often unable to treat large numbers of 
stroke patients for whom time of stroke is unknown.  Sanchez therefore altered his research 
objectives, in association with clinical knowledge users, in order to find clinically useful 
biomarkers determining the time a stroke occurred.  KT, in this case, is ‘built into’ the research 
design. 
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Outreach KT 
There is growing interest in science outreach to the public (Varner, 2014). Yet many scientists 
do not acknowledge its importance or are ill prepared to engage in outreach due to a lack of 
training opportunities to learn such skills (Dobbins, 2007; Varner 2014). In an effort to correct 
this, Varner (2014) for example, publishes a supplementary table that lists the online resources 
available for learning more about effective public communication of science. Discussion of 
scientific outreach is not commonly found in the KT literature.  Instead, it is usually the realm of 
experts on science education, science communication, or public understanding of science.  
However, from the viewpoint of the scientists we interviewed, it is part of a continuum of KT 
activities.  In other words, when asked about KT in proteomics and how proteomics was 
perceived, proteomics scientists would often bring up issues that would be categorized as 
scientific outreach, in addition to issues which are more widely recognized within the KT 
literature.  We therefore felt it was important to include outreach in our consideration of KT 
strategies within proteomics. 
 
After some twenty years of social scientists studying public understanding of science, the key 
shift has been from incorrectly assuming the public has a deficit in scientific understanding (i.e., 
an information transfer model) to working on ways to foster engagement and dialogue with the 
public about science (Metcalfe, 2013; Stilgoe et al., 2014).  In other words, KT should be seen as 
an iterative process between scientists and other actors (Einsiedel, 2006; Stilgoe et al., 2014). In 
order to be effective, the goals of public outreach, i.e., to engage the public rather than to 
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inform the public, should be well defined and ideally also targeted to a specific audience 
(Varner, 2014).  But hybrid approaches to public outreach, which include both dialogue and 
information, are also possible.  Varner (2014) further argues that more time spent developing 
and evaluating outreach strategies would increase their effectiveness.  
 
Methods for outreach can include the use of tools intended to reach a broad audience, for 
example, mainstream media, TED talks, Twitter, blogs, You Tube, etc. Other techniques include 
educational sessions and massive open online courses (MOOC) for public audiences.  These 
techniques have been endorsed in the science communication literature as an easy and safe 
first step in fostering dialogues about science, particularly as the internet is the public’s favored 
source of scientific news and information (Varner, 2014). 
 
We saw these techniques employed by various proteomics researchers who spoke of two 
audiences for outreach, the general public and funders. In both cases the aim is to increase 
understanding about proteomics and the potential that it holds.  The following excerpt shows 
an interest in outreach to both of those audiences. 
We go out and we talk to the donors of the [funding organization] – all my lab members 
always go to those things. And I say to my lab people – you can’t just sit and talk to 
yourself at the fundraiser breakfast, you’ve got to go and speak to at least two donors 
each and tell them what you are doing and thank them, so we do that. And we have 
high school kids come and work in the lab and we do actually use the press more and 
more now. I mean, I felt awful, I felt bad, like you are self-promoting, but we do it now 
because you actually realize the public has to see and feel good about it, because it is 
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their money. I mean their tax money could go to science or alternatively it could go to 
buying a war plane or it could go to a hospital, so you’ve actually got to get that 
awareness out. (PS2)  
 
This scientist underlines the important point of opportunity costs - that money spent on 
proteomics could alternately be spent on something else.  Further, he suggests that the public 
is already engaged, to some extent, in this choice between the costs and opportunities which 
are represented by proteomics science (as opposed to other kinds of science or, in fact, as 
opposed to something other than science).  This acknowledgement of the responsibility of 
scientists to the public is increasingly part of the discussion about why public outreach is 
important (Stilgoe  et al., 2014; Wilsdon et al., 2005).   
 
Some of the scientists we have interviewed and listened to recognized that participating in this 
kind of public outreach meant finding ways of describing proteomics with which a lay audience 
could engage.  For instance, this quote suggests that analogies and metaphor may be helpful 
communications tools. 
There is a Ted Med Talk I saw yesterday. It actually used the car analogy that I have used 
for many years. But he also used a street analogy as the way in which proteins produced 
by genes move around a cell. You know, you tend to the restaurants in one area, the 
galleries in one area, and he was saying that Manhattan is a bit like a cell where 
particular activities occur in particular locations, that proteins can move around 
between them. He used that; it was really cool. So I think that is the sort of thing that I 
would love to see —communicate with the public more because I think one of the 
23 
 
problems is that we are not getting a good PhD stream coming through in this area of 
science, at present. (PS3) 
 
This scientist again highlights the issue discussed earlier about targeted KT, of using KT 
strategies as a means to try to increase the number and quality of students who are interested 
in proteomics research, as well as the importance of using communication tools to expand the 
awareness, knowledge and understanding of the lay public.  While many suggested that 
outreach was important, some also suggested that finding time to do this properly was also a 
considerable challenge. 
Since our field - proteomics - is very technical I would see that we as a community be 
more involved in outreach activities to the general public [so] that they do understand 
what we can do. Give me a drop of blood and [it will] tell you these are the proteins and 
[they will] tell you something about your health status. But, we are all very busy (PS1).  
 
Despite this challenge, some proteomics researchers are engaging innovatively in public 
outreach. For instance, Sanjeeva Srivastava, who presented at HUPO 2013, suggested that 
outreach was very important for the public to understand the potential of proteomics science.  
This motivated him to invest time in e-learning, including the creation of virtual labs, MOOCS, 
You Tube lectures, and academic engagement with e-learning (Sakshat Virtual Labs, 2016; 
Srivastava, 2013).  This approach to public engagement reflects, in general, an information 
transfer model, where the public needs to be educated about the science and its potential.  It 
could also provide a foundation for movement into a public dialogue about proteomics that the 
public understanding of science field has pinpointed as a crucial next step.  
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A focus on public outreach is also increasingly seen in the operations of HUPO.  In the 2015 
Annual General Meeting, the President of HUPO noted that the HUPO intended to establish a 
HPP ‘marketing committee’ to promote the HPP to the pharmaceutical and biotechnological 
industry, students, and the media in order to take proteomics to the public.  In some ways, 
then, the move to organize proteomics research using a model from genomics research that 
was already familiar to funders and, in some respect, to the public, is another way in which 
HUPO aims to enable public outreach.  Familiarity with the manner in which research is 
organized may enable meaningful dialogue, as well as the transfer of information, particularly 
to funders of research. 
 
It is worth cautioning, however, that a reliance on models that worked for genomics may not 
always work for the other omics sciences.  We have argued elsewhere (Holmes et al., 2016) that 
the ‘gene’ and therefore genomics hold cultural importance for society at large that is often not 
shared by proteins, RNA, and metabolites, making it easier to communicate genomics to the 
public.  While genetics and genomics are supported by cultural explanations of traits being ‘in 
the blood’ that go back hundreds of years, newer omics sciences associated with RNA, proteins, 
etc. do not have the same access to prevalent cultural explanations.  In discussing the cultural 
importance of genetics and genomics with a proteomics researcher after an interview, he 
corroborated that genomics had an advantage in this area as genomics was culturally 
understood as being trait related, ‘whereas protein is just something you eat’ (PS8).  It was one 
reason, he said, why he continued his involvement in an applied proteomics project, so as to be 
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able to effectively communicate proteomics to a broader audience.  Proteomics, and indeed, 
other omics sciences, may have to find new ways to explain what they do to a wider audience.   
 
Discussion 
In the current research environment there is an increasing recognition by funders and by 
scientists of the need for enhanced knowledge translation and dissemination of research 
outcomes beyond the traditional forms (Estabrooks et al., 2008; Tetroe et al., 2008). Yet key 
barriers to academics engaging more effectively and broadly in KT include:  
 the effort it takes to sustain collaborative relationships;  
 the products of less traditional forms of KT are not always highly valued for funding, 
hiring, tenure, and promotion; and  
 scientists lack the communication skills to present their findings in clear, accessible 
language (Dobbins et al., 2007; Estabrooks et al., 2008).   
 
These are serious barriers that can be overcome with a clear KT goal and knowledge user input.  
Graham et al. (2006) suggest that knowledge producers increase the use of their research by 
highlighting: What should be disseminated?, To whom?, By whom?, How?, and With what 
effect?  Active engagement with these kinds of questions will increase the engagement of 
others with proteomics and make it easier for researchers to more clearly articulate their place 
in broader public debates about the public value of science, in which issues of public 
engagement are crucial (Stilgoe et al., 2014). 
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While some research funders are requiring the integration of ELSI (ethical, legal, and social 
implications of science and technology) (Lopez and Lunau, 2012) research into scientific 
research under integrated projects, it is important to recognize that this is not synonymous 
with increasing KT in the way it is understood in the KT literature.  While increasing social 
scientific, legal, or ethical perspectives on technological innovation may improve the fit of 
technological innovation to society, the KT literature itself is focused on a direct relationship 
with the knowledge users themselves.  
 
In respect of proteomics science, proteomics scientists by default actively engage in traditional 
KT.  We found considerable interest amongst some scientists in employing broader KT 
strategies, although the level of this interest varied considerably.  However, researchers also 
expressed concern that the time required for outreach, integrated, or targeted KT reduced the 
time available for traditional KT and the publications that are required for grants and career 
advancement. There was increasing recognition of the need for targeted KT, with proteomics 
scientists claiming that the field has matured sufficiently to contribute to functional genomics, 
systems biology and clinical research.  In this context then the proteomics scientists we 
interviewed and those who discussed these issues in conferences identified knowledge users as 
scientists in closely related fields and students.  Methods included improving educational 
opportunities for students, publication in the journals of related fields and attendance of 
conferences in those fields, as well as organizational initiatives to create and present 
knowledge in a way in which knowledge could be more easily used by genomics and those 
omics sciences that used genomics as a touchstone.   
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Integrated KT is comparatively rare in the proteomics community and mostly encompasses the 
concept of working in multi-disciplinary teams, which does not necessarily constitute 
integration in its purest sense.  Truly integrated projects remain rare because they require a 
level of commitment to collaboration that involves significant energy and effort, not to mention 
anticipatory thinking so as to incorporate, when possible, the knowledge users in the 
“upstream” research agenda and design processes.  Nevertheless, we did find examples of this 
kind of KT. In some research, clinicians were identified as knowledge users and they were 
brought into the research at the design stage to make it more pertinent.  We note that 
concerns over the time and effort involved in these kinds of KT are an important factor 
determining their ease of implementation and success. 
 
In contrast to the effort of integrated KT projects, public outreach KT can require as little as 140 
characters on Twitter.  Our qualitative research suggests a higher level of engagement by 
proteomics scientists with public outreach KT strategies.  This could be attributed to forms of 
interaction, such as social media, that involve minimal commitment of time and resources.  It 
might also be attributed to scientists perceiving obligations inherent in accepting public funding 
for science.  There may also be an increasing recognition that when funders choose to fund (or 
not) proteomics, they are also making funding choices about some other field of science. These 
decisions are informed by a general understanding (or not) of the science, how it operates, and 
its potential.  Generally, the examples we observed with proteomics scientists and outreach KT 
focused on information transfer, rather than fostering an ongoing dialogue with the public, so 
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there is an opportunity for proteomics to expand into forms of outreach that truly engage lay 
audiences.  In considering outreach KT strategies for proteomics, we also caution that 
approaches that have been successful for genomics in the past should be evaluated carefully for 
their use with proteomics, given that our review of the literature on genomics and society 
shows that genomics is associated with deeply held cultural explanations which, we argue, 
often do not carry over to proteomics (Holmes et al., 2016).  Indeed, in terms of the social 
scientific study of the new omics sciences, we argue that social science must expect that the 
social implications of other omics sciences may play out very differently than they did for 
genomics (Holmes et al., 2016).   
 
It is also worthwhile to comment on the extent to which proteomics scientists might engage 
with social science and humanities research concerning emerging technology knowledge 
domains such as proteomics. A recent analysis on the concept of anticipatory or early 
technology assessment by Steuten (2016) provides useful insights in this regard, from the works 
by later Nobel Prize winner Frederick Soddy—who in the year 1915 forecasted the social 
consequences of atomic energy (i.e., an atomic bomb) long before atomic energy became a 
mainstream idea. Accordingly, Steuten (2016) observes that  
Importantly, to achieve his insights, Soddy supplemented scientific knowledge and 
logical argument with so-called “nonscientific” sources including contemporary 
politics, social context, emotion, and imagination. This example provides strong 
evidence for the informative value of multiple sources of knowledge in technology 
assessment, most eloquently described by Sclove, 1989: ‘‘After all, many scientists 
shared Soddy’s scientific knowledge, but none became as committed as he to 
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investigate the social implications of that knowledge, much less reached conclusions 
or comparable power.’” (Steuten 2016; Sclove 1989). 
 
It is evident, however, from our social science data that the value of layered and targeted 
dissemination strategies promoted in the KT literature are recognized in the strategies of 
proteomics scientists.  To embrace such strategies, proteomics scientists must still fight the 
entrenched conventions of scientific practice, perhaps similar to the early works by Soddy 
noted above.  The requirements of traditional KT within academia are firmly linked to tenure, 
promotion, and research funding, whereas forms of targeted KT, integrated KT, and outreach 
KT have been less valued.  In this respect, proteomics scientists might need to challenge their 
own normative approaches to dissemination (i.e., their ranking of what forms of dissemination 
are and are not important) when serving on grant funding committees and evaluating 
colleagues.  This is in addition to making their own decisions about which knowledge users they 
wish to reach with their research, and the best methods to do this.  In light of this, further 
exploration of the balance between structural/organizational factors (e.g., entrenched 
academic conventions, the HUPO’s efforts to support targeted engagement) and individual 
factors (e.g., a particular scientist’s affinity for social media) in the pursuit of different KT 
strategies may be valuable.  
 
As a final note, we suggest that while there are many benefits to a field in expanding the kinds 
of KT in which they engage, there is also the possibility that too much pressure on forms such as 
integrated KT or the needs of knowledge users may lead to suggestions that scientific 
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independence may be compromised (Heath, 1998).  Indeed, some scientists may place higher 
value on curiosity-driven research than that driven by knowledge users. An individual scientist 
might need to consider at which stage these different values are competing, where they 
overlap, and how and when each should be prioritized. 
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